Figures & data
Figure 1. Planned accrual design. (a) Schema for sequential single-agent lead-in to doublet therapy. (b) Following a protocol amendment, sequential lead-in was eliminated and all patients were enrolled to doublet therapy upfront.
![Figure 1. Planned accrual design. (a) Schema for sequential single-agent lead-in to doublet therapy. (b) Following a protocol amendment, sequential lead-in was eliminated and all patients were enrolled to doublet therapy upfront.](/cms/asset/4d672aee-f520-4903-b515-b637b584a834/icnv_a_1983584_f0001_b.jpg)
Table 1. Baseline patient characteristics.
Table 2. Best response by treatment arm and drug.
Table 3. Adverse events.